ArticleThe journal of allergy and clinical immunology. Global2026
BRIDGE implementation science study to improve chronic spontaneous urticaria outcomes in Italy.
Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge of chronic spontaneous urticaria management among Italian general practitioners: Baseline findings from the BRIDGE study.The World Allergy Organization journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Delay in diagnosis and referral to a specialist negatively affects the quality of life of patients with uncontrolled chronic spontaneous urticaria (CSU). The BRIDGE implementation science study is evaluating the effectiveness and feasibility of implementing strategies aiming to improve care for patients with CSU. Objective: Our aim was to present findings from a contextual analysis of the unmet needs of CSU management in Italy and describe the design of the BRIDGE study, which was developed to address those gaps. Methods: BRIDGE is a hybrid, effectiveness-implementation science study with a pre-post design involving general practitioners (GPs). A Consolidated Framework for Implementation Research-guided contextual analysis was performed to identify barriers to and facilitators of development and implementation of a strategy aiming to improve care for patients with CSU in Italy. Results: The barriers to effective management of patients with CSU include lack of awareness of, familiarity with, and knowledge about optimal care for patients with CSU and patient-reported outcomes (PROs), as well as lack of resources for PRO assessment. Additionally, there is an absence of well-established processes and practices for collaboration and effective communication between GPs and CSU specialists. The following implementation strategies were recommended for optimization of CSU care in Italy: (1) targeted training for GPs, guidelines, and utility of PROs to support decision making; (2) development of a guide for GPs to rapidly identify patients with CSU; and (3) improvement of referral networks. Conclusions: GPs in Italy require additional education and support to improve management of patients with CSU. The BRIDGE study incorporates the aforementioned findings into development and implementation of a tailored educational program, the Urticaria Care Package, to improve care for patients with CSU in Italy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.